Autophagy-Targeting Nanomedicine: Strike at the Heart of the Cancer via Precise Modulation of Autophagy

Abstract

Autophagy is a process of engulfing cytoplasmic proteins or organelles, thereby fulfilling cells’ metabolic needs and the renewal of specific organelles. Given its key roles in tumor progression, autophagy has attracted tremendous attention in cancer therapies. Notably, there is a megatrend to integrating autophagy regulation into mainstream treatments. This review focuses on autophagy-targeting nanomedicine (ApT-NM) to modulate autophagy in tumor therapy, including the unmodified and functionalized nanoparticles that target tumors by carrying autophagy modulators. On the one hand, it can reverse treatment resistance by inhibiting protective autophagy, and on the other hand, it can promote the death of cancer cells through type II apoptosis by inducing autophagy. Moreover, advanced nanoplatforms combining various treatments (such as chemotherapy, radiotherapy, photothermal therapy, and photodynamic therapy, etc.) have also been summarized. Last, the future perspectives and directions for ApT-NM research are provided, hoping to emphasize this rising filed and promote the development of ApT-NM.

Keywords

Autophagy / Nanoplatform / Autophagy-targeting nanomedicine / Cancer therapy / Combined therapy

References

[1] R. L. Siegel, K. D. Miller, H. E. Fuchs, and A. Jemal CA: A Cancer Journal for Clinicians72 (2022): 7.

[2] a) J. Huang, Y. Huang, Z. Xue, and S. Zeng, “Tumor Microenvironment Responsive Hollow Mesoporous Co₉S₈@MnO₂-ICG/DOX Intelligent Nanoplatform for Synergistically Enhanced Tumor Multimodal Therapy,” Biomaterials262 (2020): 120346. b) K. Ulbrich, K. Hola, V. Subr, A. Bakandritsos, J. Tucek, and R. Zboril, “Targeted Drug Delivery With Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies,” Chemical Reviews116 (2016): 5338-5431.

[3] R. S. Iyer, S. R. Needham, I. Galdadas, et al., “Drug-Resistant EGFR Mutations Promote Lung Cancer by Stabilizing Interfaces in Ligand-Free Kinase-Active EGFR Oligomers,” Nature Communications15 (2024): 2130.

[4] X. Long, S. Zhang, Y. Wang, et al., “Targeting JMJD1C to Selectively Disrupt Tumor Treg Cell Fitness Enhances Antitumor Immunity,” Nature Immunology25 (2024): 525-536.

[5] a) X. Li, J. F. Lovell, J. Yoon, and X. Chen, “Clinical Development and Potential of Photothermal and Photodynamic Therapies for Cancer,” Nature Reviews Clinical Oncology17 (2020): 657-674. b) R. Alzeibak, T. A. Mishchenko, N. Y. Shilyagina, I. V. Balalaeva, M. V. Vedunova, and D. V. Krysko, “Targeting Immunogenic Cancer Cell Death by Photodynamic Therapy: Past, Present and Future,” Journal for ImmunoTherapy of Cancer9 (2021): e001926. c) S. Liang, X. Deng, P. Ma, Z. Cheng, and J. Lin, “Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy,” Advanced Materials32 (2020): e2003214.

[6] S. Bayda, M. Adeel, T. Tuccinardi, M. Cordani, and F. Rizzolio, “The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine,” Molecules (Basel, Switzerland)25 (2019): 112.

[7] a) R. van der Meel, E. Sulheim, Y. Shi, F. Kiessling, W. J. M. Mulder, and T. Lammers, “Smart Cancer Nanomedicine,” Nature Nanotechnology14 (2019): 1007-1017. b) V. K. Lakshmanan, S. Jindal, G. Packirisamy, et al., “Nanomedicine-Based Cancer Immunotherapy: Recent Trends and Future Perspectives,” Cancer Gene Therapy28 (2021): 911-923. c) A. Parodi, P. Buzaeva, D. Nigovora, et al., “Nanomedicine for Increasing the Oral Bioavailability of Cancer Treatments,” Journal of Nanobiotechnology19 (2021): 354. d) P. Zhang, Y. Zhai, Y. Cai, Y. Zhao, and Y. Li, “Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis,” Advanced Materials31 (2019): e1904156.

[8] a) L. Yan, Y. Yang, W. Zhang, and X. Chen, “Advanced Materials and Nanotechnology for Drug Delivery,” Advanced Materials26 (2014): 5533-5540. b) Z. Li, Y. Liu, X. Fang, and Z. Shu, “Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy,” International Journal Nanomedicine16 (2021): 1631-1661. c) D. Chen, Z. Jin, B. Zhao, Y. Wang, and Q. He, “MBene as a Theranostic Nanoplatform for Photocontrolled Intratumoral Retention and Drug Release,” Advanced Materials33 (2021): e2008089.

[9] a) Y. Wang, Y. X. Lin, Z. Y. Qiao, et al., “Self-Assembled Autophagy-Inducing Polymeric Nanoparticles for Breast Cancer Interference In-Vivo,” Advanced Materials27 (2015): 2627-2634. b) G. B. Ding, J. Sun, G. Wu, et al., “Robust Anticancer Efficacy of a Biologically Synthesized Tumor Acidity-Responsive and Autophagy-Inducing Functional Beclin 1,” ACS Applied Materials & Interfaces10 (2018): 5227-5239.

[10] I. Dikic and Z. Elazar, “Mechanism and Medical Implications of Mammalian Autophagy,” Nature Reviews Molecular Cell Biology19 (2018): 349-364.

[11] a) Y. Feng, D. He, Z. Yao, and D. J. Klionsky, “The Machinery of Macroautophagy,” Cell Research24 (2014): 24-41. b) N. Mizushima and M. Komatsu, “Autophagy: Renovation of Cells and Tissues,” Cell147 (2011): 728-741.

[12] B. Levine and G. Kroemer, “Biological Functions of Autophagy Genes: A Disease Perspective,” Cell176 (2019): 11-42.

[13] a) P. Lorincz and G. Juhasz, “Autophagosome-Lysosome Fusion,” Journal of Molecular Biology432 (2020): 2462-2482. b) B. Zhou, J. Liu, R. Kang, D. J. Klionsky, G. Kroemer, and D. Tang, “Ferroptosis is a Type of Autophagy-Dependent Cell Death,” Seminars in Cancer Biology66 (2020): 89-100.

[14] D. R. Miller and A. Thorburn, “Autophagy and Organelle Homeostasis in Cancer,” Developmental Cell56 (2021): 906-918.

[15] a) D. C. Rubinsztein, T. Shpilka, and Z. Elazar, “Mechanisms of Autophagosome Biogenesis,” Current Biology22 (2012): R29-R34. b) S. Alers, A. S. Loffler, F. Paasch, et al., “Atg13 and FIP200 Act Independently of Ulk1 and Ulk2 in Autophagy Induction,” Autophagy7 (2011): 1424-1433. c) I. G. Ganley, H. Lam du, J. Wang, X. Ding, S. Chen, and X. Jiang, “ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and is Essential for Autophagy,” Journal of Biological Chemistry284 (2009): 12297-12305. d) H. Yamamoto, Y. Fujioka, S. W. Suzuki, et al., “The Intrinsically Disordered Protein Atg13 Mediates Supramolecular Assembly of Autophagy Initiation Complexes,” Developmental Cell38 (2016): 86-99.

[16] a) B. Bilanges, S. Alliouachene, W. Pearce, et al., “Vps34 PI 3-kinase Inactivation Enhances Insulin Sensitivity Through Reprogramming of Mitochondrial Metabolism,” Nature Communications8 (2017): 1804. b) K. Obara, T. Sekito, and Y. Ohsumi, “Assortment of Phosphatidylinositol 3-Kinase Complexes—Atg14p Directs Association of Complex I to the Pre-Autophagosomal Structure in Saccharomyces Cerevisiae,” Molecular Biology of the Cell17 (2006): 1527-1539. c) K. Obara and Y. Ohsumi, “Dynamics and Function of PtdIns(3) P in Autophagy,” Autophagy4 (2008): 952-954.

[17] a) Z. Yang and D. J. Klionsky, “Mammalian Autophagy: Core Molecular Machinery and Signaling Regulation,” Current Opinion in Cell Biology22 (2010): 124-131. b) Y. Xie, R. Kang, X. Sun, et al., “Posttranslational Modification of Autophagy-Related Proteins in Macroautophagy,” Autophagy11 (2015): 28-45.

[18] T. Kirisako, Y. Ichimura, H. Okada, et al., “The Reversible Modification Regulates the Membrane-Binding State of Apg8/Aut7 Essential for Autophagy and the Cytoplasm to Vacuole Targeting Pathway,” Journal of Cell Biology151 (2000): 263-276.

[19] a) Y. Kabeya, N. Mizushima, A. Yamamoto, S. Oshitani-Okamoto, Y. Ohsumi, and T. Yoshimori, “LC3, GABARAP and GATE16 Localize to Autophagosomal Membrane Depending on Form-II Formation,” Journal of Cell Science117 (2004): 2805-2812. b) L. Wang, M. Chen, J. Yang, and Z. Zhang, “LC3 Fluorescent Puncta in Autophagosomes or in Protein Aggregates Can be Distinguished by FRAP Analysis in Living Cells,” Autophagy9 (2013): 756-769. c) X. Bai, X. Yang, X. Jia, et al., “CAV1-CAVIN1-LC3B-Mediated Autophagy Regulates High Glucose-Stimulated LDL Transcytosis,” Autophagy16 (2020): 1111-1129.

[20] a) J. Zhang, P. Wang, L. Wan, S. Xu, and D. Pang, “The Emergence of Noncoding RNAs as Heracles in Autophagy,” Autophagy13 (2017): 1004-1024. b) Z. An, A. Tassa, C. Thomas, et al., “Autophagy is Required for G 1/G 0 Quiescence in Response to Nitrogen Starvation in Saccharomyces Cerevisiae,” Autophagy10 (2014): 1702-1711.

[21] a) X. Li, S. He, and B. Ma, “Autophagy and Autophagy-Related Proteins in Cancer,” Molecular Cancer19 (2020): 12. b) W. Chen, L. Zhang, K. Zhang, et al., “Reciprocal Regulation of Autophagy and dNTP Pools in Human Cancer Cells,” Autophagy10 (2014): 1272-1284.

[22] a) Y. A. Lee, L. A. Noon, K. M. Akat, et al., “Autophagy is a Gatekeeper of Hepatic Differentiation and Carcinogenesis by Controlling the Degradation of Yap,” Nature Communications9 (2018): 4962. b) Z. J. Yang, C. E. Chee, S. Huang, and F. A. Sinicrope, “The Role of Autophagy in Cancer: Therapeutic Implications,” Molecular Cancer Therapeutics10 (2011): 1533-1541. c) R. K. Amaravadi, D. Yu, J. J. Lum, et al., “Autophagy Inhibition Enhances Therapy-Induced Apoptosis in a Myc-Induced Model of Lymphoma,” Journal of Clinical Investigation117 (2007): 326-336.

[23] K. Yamamoto, A. Venida, J. Yano, et al., “Autophagy Promotes Immune Evasion of Pancreatic Cancer by Degrading MHC-I,” Nature581 (2020): 100-105.

[24] Z. Wang, F. Yin, J. Xu, et al., “CYT997(Lexibulin) Induces Apoptosis and Autophagy Through the Activation of Mutually Reinforced ER Stress and ROS in Osteosarcoma,” Journal of Experimental & Clinical Cancer Research38 (2019): 44.

[25] P. O. Seglen and P. B. Gordon, “3-Methyladenine: Specific Inhibitor of Autophagic/Lysosomal Protein Degradation in Isolated Rat Hepatocytes,” Proceedings of the National Academy of Sciences79 (1982): 1889-1892.

[26] X. Cheng, H. Feng, H. Wu, et al., “Targeting Autophagy Enhances Apatinib-Induced Apoptosis via Endoplasmic Reticulum Stress for Human Colorectal Cancer,” Cancer Letters431 (2018): 105-114.

[27] R. A. Barnard, L. A. Wittenburg, R. K. Amaravadi, D. L. Gustafson, A. Thorburn, and D. H. Thamm, “Phase I Clinical Trial and Pharmacodynamic Evaluation of Combination Hydroxychloroquine and Doxorubicin Treatment in Pet Dogs Treated for Spontaneously Occurring Lymphoma,” Autophagy10 (2014): 1415-1425.

[28] S. P. Arora, L. Tenner, J. Sarantopoulos, et al., “Modulation of Autophagy: A Phase II Study of Vorinostat Plus Hydroxychloroquine versus Regorafenib in Chemotherapy-Refractory Metastatic Colorectal Cancer (mCRC),” British Journal of Cancer127 (2022): 1153-1161.

[29] a) M. McMahon, M. Bogdan, M. J. Timson, et al., “Abstract 3600: DCC-3116, a First-in-Class Selective Inhibitor of ULK1/2 Kinases and Autophagy, Synergizes With the KRASG12C Inhibitor Sotorasib Resulting in Tumor Regression in KRAS Mutant NSCLC Xenograft Models,” Cancer Research82 (2022): 3600. b) M. Bogdan, M. J. Timson, H. Al-Hashimi, Y. Zhan, B. D. Smith, and D. L. Flynn, “Abstract P084: DCC-3116, a First-in-Class Selective Inhibitor of ULK1/2 Kinases and Autophagy, Synergizes With EGFR Inhibitors Osimertinib and Afatinib in NSCLC Preclinical Models,” Molecular Cancer Therapeutics20 (2021): P084. c) M. Bogdan, M. J. Timson, H. Al-Hashimi, B. D. Smith, and D. L. Flynn, “Abstract 4872: DCC-3116, a First-in-Class Selective ULK1/2 Inhibitor of Autophagy, in Combination With the KIT Inhibitor Ripretinib Induces Complete Regressions in GIST Preclinical Models,” Cancer Research83 (2023): 4872.

[30] a) F. Zhang, H. Wang, J. Yu, et al., “LncRNA CRNDE Attenuates Chemoresistance in Gastric Cancer via SRSF6-regulated Alternative Splicing of PICALM,” Molecular Cancer20 (2021): 6. b) L. Peng, H. Sang, S. Wei, et al., “CircCUL2 Regulates Gastric Cancer Malignant Transformation and Cisplatin Resistance by Modulating Autophagy Activation via miR-142-3p/ROCK2,” Molecular cancer19 (2020): 156. c) Y. Qin, J. Qiu, P. Wang, et al., “Impaired Autophagy in Microglia Aggravates Dopaminergic Neurodegeneration by Regulating NLRP3 Inflammasome Activation in Experimental Models of Parkinson's Disease,” Brain, Behavior, and Immunity91 (2021): 324-338.

[31] a) J. Mandrioli, R. D'Amico, E. Zucchi, et al., “Randomized, Double-Blind, Placebo-Controlled Trial of Rapamycin in Amyotrophic Lateral Sclerosis,” Nature Communications14 (2023): 4970. b) J. A. Palma, J. Martinez, P. Millar Vernetti, et al., “mTOR Inhibition With Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis,” Movement Disorders37 (2022): 778-789.

[32] H. Wu, C. Liu, Q. Yang, et al., “MIR145-3p Promotes Autophagy and Enhances Bortezomib Sensitivity in Multiple Myeloma by Targeting HDAC4,” Autophagy16 (2020): 683-697.

[33] J. Wang, T. Hu, Q. Wang, et al., “Repression of the AURKA-CXCL5 Axis Induces Autophagic Cell Death and Promotes Radiosensitivity in Non-Small-Cell Lung Cancer,” Cancer Letters509 (2021): 89-104.

[34] a) H. J. Cheng, T. H. Wu, C. T. Chien, H. W. Tu, T. S. Cha, and S. Y. Lin, “Corrosion-Activated Chemotherapeutic Function of Nanoparticulate Platinum as a Cisplatin Resistance-Overcoming Prodrug With Limited Autophagy Induction,” Small12 (2016): 6124-6133. b) V. R. Lopes, V. Loitto, J. N. Audinot, N. Bayat, A. C. Gutleb, and S. Cristobal, “Dose-Dependent Autophagic Effect of Titanium Dioxide Nanoparticles in Human HaCaT Cells at Non-Cytotoxic Levels,” J Nanobiotechnology14 (2016): 22. c) Z. Cui, Y. Zhang, K. Xia, et al., “Nanodiamond Autophagy Inhibitor Allosterically Improves the Arsenical-Based Therapy of Solid Tumors,” Nature Communications9 (2018): 4347. d) D. Cui, J. Ma, T. Liang, et al., “Selenium Nanoparticles Fabricated in Laminarin Polysaccharides Solutions Exert Their Cytotoxicities in HepG2 Cells by Inhibiting Autophagy and Promoting Apoptosis,” International Journal of Biological Macromolecules137 (2019): 829-835. e) S. Azimee, M. Rahmati, H. Fahimi, and M. A. Moosavi, “TiO₂ Nanoparticles Enhance the Chemotherapeutic Effects of 5-Fluorouracil in Human AGS Gastric Cancer Cells via Autophagy Blockade,” Life Sciences248 (2020): 117466.

[35] H. Y. Zhang, Z. X. Ji, T. Xia, et al., “Use of Metal Oxide Nanoparticle Band Gap To Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation,” ACS Nano6 (2012): 4349-4368.

[36] L. Pan, H. Peng, B. Lee, et al., “Cascade Catalytic Nanoparticles Selectively Alkalize Cancerous Lysosomes to Suppress Cancer Progression and Metastasis,” Advanced Materials36 (2024): e2305394.

[37] a) L. Zhang, J. Zhao, X. Hu, et al., “A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy Against Solid Tumors,” Advanced Materials34 (2022): e2206915. b) L. Zhang, Y. Jia, J. Yang, et al., “Efficient Immunotherapy of Drug-Free Layered Double Hydroxide Nanoparticles via Neutralizing Excess Acid and Blocking Tumor Cell Autophagy,” Acs Nano16 (2022): 12036-12048.

[38] N. Hoshyar, S. Gray, H. Han, and G. Bao, “The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction,” Nanomedicine11 (2016): 673-692.

[39] M. X. Wu and Y. W. Yang, “Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy,” Advanced Materials29 (2017): 1606134.

[40] H. Zheng, Y. Zhang, L. Liu, et al., “One-Pot Synthesis of Metal-Organic Frameworks With Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery,” Journal of the American Chemical Society138 (2016): 962-968.

[41] Z. Shi, X. Chen, L. Zhang, et al., “FA-PEG Decorated MOF Nanoparticles as a Targeted Drug Delivery System for Controlled Release of an Autophagy Inhibitor,” Biomater Sci6 (2018): 2582-2590.

[42] X. Chen, R. Tong, Z. Shi, et al., “MOF Nanoparticles With Encapsulated Autophagy Inhibitor in Controlled Drug Delivery System for Antitumor,” ACS Applied Materials & Interfaces10 (2018): 2328-2337.

[43] X. Chen, Y. Tao, M. He, et al., “Co-Delivery of Autophagy Inhibitor and Gemcitabine Using a pH-Activatable Core-Shell Nanobomb Inhibits Pancreatic Cancer Progression and Metastasis,” Theranostics11 (2021): 8692-8705.

[44] M. Jing, Y. Li, M. Wang, et al., “Photoresponsive PAMAM-Assembled Nanocarrier Loaded With Autophagy Inhibitor for Synergistic Cancer Therapy,” Small17 (2021): e2105995.

[45] Y. Deng, F. Jia, P. Jiang, et al., “Biomimetic Nanoparticle Synchronizing Pyroptosis Induction and Mitophagy Inhibition for Anti-Tumor Therapy,” Biomaterials301 (2023): 122293.

[46] Z. Ma, J. Li, K. Lin, et al., “Pharmacophore Hybridisation and Nanoscale Assembly to Discover Self-Delivering Lysosomotropic New-Chemical Entities for Cancer Therapy,” Nature Communications11 (2020): 4615.

[47] V. Voss, C. Senft, V. Lang, et al., “The Pan-Bcl-2 Inhibitor (−)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma,” Molecular Cancer Research8 (2010): 1002-1016.

[48] W. Bai, Y. Chen, P. Sun, and A. Gao, “Downregulation of B-Cell Lymphoma/Leukemia-2 by Overexpressed MicroRNA 34a Enhanced Titanium Dioxide Nanoparticle-Induced Autophagy in BEAS-2B Cells,” International Journal of Nanomedicine11 (2016): 1959-1971.

[49] G. He, Y. Ma, Y. Zhu, et al., “Cross Talk Between Autophagy and Apoptosis Contributes to ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death,” Advanced Healthcare Materials7 (2018): e1800332.

[50] a) N. Mozdoori, S. Safarian, and N. Sheibani, “Augmentation of the Cytotoxic Effects of Zinc Oxide Nanoparticles by MTCP Conjugation: Non-Canonical Apoptosis and Autophagy Induction in Human Adenocarcinoma Breast Cancer Cell Lines,” Materials Science & Engineering C-Materials for Biological Applications78 (2017): 949-959. b) D. P. Bai, X. F. Zhang, G. L. Zhang, Y. F. Huang, and S. Gurunathan, “Zinc Oxide Nanoparticles Induce Apoptosis and Autophagy in Human Ovarian Cancer Cells,” International Journal of Nanomedicine12 (2017): 6521-6535. c) J. Wang, S. Gao, S. Wang, Z. Xu, and L. Wei, “Zinc Oxide Nanoparticles Induce Toxicity in CAL 27 Oral Cancer Cell Lines by Activating PINK1/Parkin-Mediated Mitophagy,” International Journal of Nanomedicine13 (2018): 3441-3450. d) F. Li, L. Song, X. Yang, et al., “Anticancer and Genotoxicity Effect of (Clausena lansium (Lour.) Skeels) Peel ZnONPs on Neuroblastoma (SH-SY5Y) Cells Through the Modulation of Autophagy Mechanism,” Journal of Photochemistry and Photobiology B: Biology203 (2020): 111748.

[51] a) L. Fageria, V. Bambroo, A. Mathew, S. Mukherjee, R. Chowdhury, and S. Pande, “Functional Autophagic Flux Regulates AgNP Uptake and the Internalized Nanoparticles Determine Tumor Cell Fate by Temporally Regulating Flux,” International Journal of Nanomedicine14 (2019): 9063-9076. b) M. A. Farah, M. A. Ali, S. M. Chen, et al., “Silver Nanoparticles Synthesized From Adenium Obesum Leaf Extract Induced DNA Damage, Apoptosis and Autophagy via Generation of Reactive Oxygen Species,” Colloids and Surfaces. B, Biointerfaces141 (2016): 158-169.

[52] X. F. Zhang and S. Gurunathan International Journal of Nanomedicine11 (2016): 3655.

[53] Y. L. Cho, H. W. S. Tan, Q. Saquib, et al., “Dual Role of Oxidative Stress-JNK Activation in Autophagy and Apoptosis Induced by Nickel Oxide Nanoparticles in Human Cancer Cells,” Free Radical Biology and Medicine153 (2020): 173-186.

[54] E. Mari, S. Mardente, E. Morgante, et al., “Graphene Oxide Nanoribbons Induce Autophagic Vacuoles in Neuroblastoma Cell Lines,” International Journal of Molecular Sciences17 (2016): 1995.

[55] Y. G. Yuan, Y. H. Wang, H. H. Xing, and S. Gurunathan, “Quercetin-Mediated Synthesis of Graphene Oxide-Silver Nanoparticle Nanocomposites: A Suitable Alternative Nanotherapy for Neuroblastoma,” Int J Nanomedicine12 (2017): 5819-5839.

[56] Q. Zhang, W. Yang, N. Man, et al., “Autophagy-Mediated Chemosensitization in Cancer Cells by Fullerene C60 Nanocrystal,” Autophagy5 (2009): 1107-1117.

[57] C. W. Wong, A. V. Zhilenkov, O. A. Kraevaya, D. V. Mischenko, P. A. Troshin, and S. H. Hsu, “Toward Understanding the Antitumor Effects of Water-Soluble Fullerene Derivatives on Lung Cancer Cells: Apoptosis or Autophagy Pathways?,” Journal of Medicinal Chemistry62 (2019): 7111-7125.

[58] M. Machtakova, H. Therien-Aubin, and K. Landfester, “Polymer Nano-Systems for the Encapsulation and Delivery of Active Biomacromolecular Therapeutic Agents,” Chem. Soc. Rev.51 (2022): 128-152.

[59] a) S. Sarkar and N. Levi-Polyachenko, “Conjugated Polymer Nano-Systems for Hyperthermia, Imaging and Drug Delivery,” Advanced Drug Delivery Reviews163-164 (2020): 40-64. b) L. Yang, H. Sun, Y. Liu, et al., “Self-Assembled Aptamer-Grafted Hyperbranched Polymer Nanocarrier for Targeted and Photoresponsive Drug Delivery,” Angewandte Chemie (International Edition in English)57 (2018): 17048-17052.

[60] a) Y. Hao, Y. Chen, X. He, et al., “Polymeric Nanoparticles With ROS-Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon Cancer,” Advanced Science7 (2020): 2001853. b) D. Cui, J. Huang, X. Zhen, J. Li, Y. Jiang, and K. Pu, “A Semiconducting Polymer Nano-Prodrug for Hypoxia-Activated Photodynamic Cancer Therapy,” Angewandte Chemie (International Edition in English)58 (2019): 5920-5924. c) S. He, J. Liu, C. Zhang, J. Wang, and K. Pu, “Semiconducting Polymer Nano-Regulators With Cascading Activation for Photodynamic Cancer Immunotherapy,” Angewandte Chemie (International Edition in English)61 (2022): e202116669.

[61] Y. X. Lin, Y. J. Gao, Y. Wang, et al., “pH-Sensitive Polymeric Nanoparticles With Gold(I) Compound Payloads Synergistically Induce Cancer Cell Death Through Modulation of Autophagy,” Molecular Pharmaceutics12 (2015): 2869-2878.

[62] Y. X. Lin, Y. Wang, S. L. Qiao, et al., “pH-Sensitive Polymeric Nanoparticles Modulate Autophagic Effect via Lysosome Impairment,” Small12 (2016): 2921-2931.

[63] a) S. K. Rehman, J. Haynes, E. Collignon, et al., “Colorectal Cancer Cells Enter a Diapause-Like DTP State to Survive Chemotherapy,” Cell184 (2021): 226-242.e21. b) W. P. Xu, J. P. Liu, J. F. Feng, et al., “miR-541 Potentiates the Response of Human Hepatocellular Carcinoma to Sorafenib Treatment by Inhibiting Autophagy,” Gut69 (2020): 1309-1321.

[64] a) P. M. Grierson, P. B. Dodhiawala, Y. Cheng, et al. Science Translational Medicine13 (2021): eabb5445. b) T. Huang, X. Wan, A. A. Alvarez, et al., “MIR93 (microRNA-93) regulates Tumorigenicity and Therapy Response of Glioblastoma by Targeting Autophagy,” Autophagy15 (2019): 1100-1111.

[65] Y. Zhao, W. Wang, S. Guo, et al., “PolyMetformin Combines Carrier and Anticancer Activities for in Vivo siRNA Delivery,” Nature Communications7 (2016): 11822.

[66] a) O. Zabirnyk, M. Yezhelyev, and O. Seleverstov, “Nanoparticles as a Novel Class of Autophagy Activators,” Autophagy3 (2007): 278-281. b) N. Mi, Y. Chen, S. Wang, et al., “CapZ Regulates Autophagosomal Membrane Shaping by Promoting Actin Assembly Inside the Isolation Membrane,” Nature Cell Biology17 (2015): 1112-1123.

[67] X. Cui, Z. Liang, J. Lu, et al., “A Multifunctional Nanodiamond-Based Nanoplatform for the Enhanced Mild-Temperature Photothermal/Chemo Combination Therapy of Triple Negative Breast Cancer via an Autophagy Regulation Strategy,” Nanoscale13 (2021): 13375-13389.

[68] a) F. D. Duman, Y. Akkoc, G. Demirci, et al., “Bypassing Pro-Survival and Resistance Mechanisms of Autophagy in EGFR-Positive Lung Cancer Cells by Targeted Delivery of 5FU Using Theranostic Ag₂S Quantum Dots,” Journal of Materials Chemistry B7 (2019): 7363-7376. b) Y. H. Miao, L. P. Mao, X. J. Cai, et al., “Zinc Oxide Nanoparticles Reduce the Chemoresistance of Gastric Cancer by Inhibiting Autophagy,” World Journal of Gastroenterology27 (2021): 3851-3862.

[69] C. Gu, X. Liu, L. Luo, et al., “Metal-DNA Nanocomplexes Enhance Chemo-Dynamic Therapy by Inhibiting Autophagy-Mediated Resistance,” Angewandte Chemie (International Edition in English)62 (2023): e202307020.

[70] a) K. L. Cook, A. Warri, D. R. Soto-Pantoja, et al., “Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in ER+ Breast Cancer,” Clinical Cancer Research20 (2014): 3222-3232. b) M. Michaelides, N. B. Stover, P. J. Francis, and R. G. Weleber, “Retinal Toxicity Associated With Hydroxychloroquine and Chloroquine,” Archives of Ophthalmology129 (2011): 30.

[71] a) R. Sun, S. Shen, Y. J. Zhang, et al., “Nanoparticle-Facilitated Autophagy Inhibition Promotes the Efficacy of Chemotherapeutics Against Breast Cancer Stem Cells,” Biomaterials103 (2016): 44-55. b) Y. Wang, S. Yin, L. Zhang, et al., “A Tumor-Activatable Particle With Antimetastatic Potential in Breast Cancer via Inhibiting the Autophagy-Dependent Disassembly of Focal Adhesion,” Biomaterials168 (2018): 1-9. c) S. Ruan, R. Xie, L. Qin, et al., “Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined With Anti-PD-L1 Antibody for Improved Glioma Treatment,” Nano Letters19 (2019): 8318-8332. d) Y. Wang, Y. Qiu, S. Yin, et al., “A Functional Nanocarrier That Copenetrates Extracellular Matrix and Multiple Layers of Tumor Cells for Sequential and Deep Tumor Autophagy Inhibitor and Chemotherapeutic Delivery,” Autophagy13 (2017): 359-370. e) X. Yang, M. Zhao, Z. Wu, et al., “Nano-Ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy,” Acs Nano16 (2022): 3417-3431.

[72] Y. Ji, X. Liu, J. Li, et al., “Use of Ratiometrically Designed Nanocarrier Targeting CDK4/6 and Autophagy Pathways for Effective Pancreatic Cancer Treatment,” Nature Communications11 (2020): 4249.

[73] Y. Gu, S. Lai, Y. Dong, et al., “AZD9291 Resistance Reversal Activity of a pH-Sensitive Nanocarrier Dual-Loaded With Chloroquine and FGFR1 Inhibitor in NSCLC,” Adv Sci (Weinh)8 (2021): 2002922.

[74] a) Y. Wu, Y. Tang, S. Xie, et al., “Chimeric Peptide Supramolecular Nanoparticles for Plectin-1 Targeted miRNA-9 Delivery in Pancreatic Cancer,” Theranostics10 (2020): 1151-1165. b) Y. X. Lin, Y. Wang, H. W. An, et al., “Peptide-Based Autophagic Gene and Cisplatin Co-Delivery Systems Enable Improved Chemotherapy Resistance,” Nano Letters19 (2019): 2968-2978. c) O. Unal, Y. Akkoc, M. Kocak, et al., “Treatment of Breast Cancer With Autophagy Inhibitory MicroRNAs Carried by AGO2-Conjugated Nanoparticles,” J Nanobiotechnology18 (2020): 65. d) Y. Zheng, C. Su, L. Zhao, and Y. Shi, “Chitosan Nanoparticle-Mediated Co-Delivery of shAtg-5 and Gefitinib Synergistically Promoted the Efficacy of Chemotherapeutics Through the Modulation of Autophagy,” Journal of Nanobiotechnology15 (2017): 28.

[75] H. Li, Q. Luo, H. Zhang, et al., “Nanomedicine Embraces Cancer Radio-Immunotherapy: Mechanism, Design, Recent Advances, and Clinical Translation,” Chem. Soc. Rev.52 (2023): 47-96.

[76] a) L. Chaiswing, H. L. Weiss, R. D. Jayswal, D. K. S. Clair, and N. Kyprianou, “Profiles of Radioresistance Mechanisms in Prostate Cancer,” Critical Reviews in Oncogenesis23 (2018): 39-67. b) K. Elsayad, L. Samhouri, S. Scobioala, U. Haverkamp, and H. T. Eich, “Is Tumor Volume Reduction During Radiotherapy Prognostic Relevant in Patients With Stage III Non-Small Cell Lung Cancer?,” Journal of Cancer Research and Clinical Oncology144 (2018): 1165-1171. c) L. G. W. Kerkmeijer, V. H. Groen, F. J. Pos, et al., “Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results from the FLAME Randomized Phase III Trial,” Journal of Clinical Oncology39 (2021): 787-796.

[77] H. E. Barker, J. T. Paget, A. A. Khan, and K. J. Harrington, “The Tumour Microenvironment After Radiotherapy: Mechanisms of Resistance and Recurrence,” Nature Reviews Cancer15 (2015): 409-425.

[78] a) T. Huang, C. K. Kim, A. A. Alvarez, et al., “MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma,” Cancer Cell32 (2017): 840-855.e8. b) D. Digomann, A. Linge, and A. Dubrovska, “SLC3A2/CD98hc, Autophagy and Tumor Radioresistance: A Link Confirmed,” Autophagy15 (2019): 1850-1851.

[79] N. Ma, P. Liu, N. He, N. Gu, F. G. Wu, and Z. Chen, “Action of Gold Nanospikes-Based Nanoradiosensitizers: Cellular Internalization, Radiotherapy, and Autophagy,” ACS Appl Mater Interfaces9 (2017): 31526-31542.

[80] H. Wu, J. Lin, P. Liu, et al., “Reactive Oxygen Species Acts as Executor in Radiation Enhancement and Autophagy Inducing by AgNPs,” Biomaterials101 (2016): 1-9.

[81] X. Zhang, Z. Liu, Z. Lou, et al., “Radiosensitivity Enhancement of Fe₃O₄@Ag Nanoparticles on human Glioblastoma Cells,” Artificial Cells, Nanomedicine, and Biotechnology46 (2018): 975-984.

[82] Q. Xu, H. Zhang, H. Liu, Y. Han, W. Qiu, and Z. Li, “Inhibiting Autophagy Flux and DNA Repair of Tumor Cells to Boost Radiotherapy of Orthotopic Glioblastoma,” Biomaterials280 (2022): 121287.

[83] Y. Li, M. H. Cho, S. S. Lee, D. E. Lee, H. Cheong, and Y. Choi, “Hydroxychloroquine-Loaded Hollow Mesoporous Silica Nanoparticles for Enhanced Autophagy Inhibition and Radiation Therapy,” J Control Release325 (2020): 100-110.

[84] T. Lin, Q. Zhang, A. Yuan, et al., “Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment,” Theranostics10 (2020): 7683-7696.

[85] Z. Yang, D. Gao, J. Zhao, et al., “Thermal Immuno-Nanomedicine in Cancer,” Nature reviews Clinical oncology20 (2023): 116-134.

[86] a) E. M. Knavel and C. L. Brace, “Tumor Ablation: Common Modalities and General Practices,” Techniques in Vascular and Interventional Radiology16 (2013): 192-200. b) Z. Zhou, Y. Sun, J. Shen, et al., “Iron/Iron Oxide Core/Shell Nanoparticles for Magnetic Targeting MRI and Near-Infrared Photothermal Therapy,” Biomaterials35 (2014): 7470-7478. c) W. Fang, S. Tang, P. Liu, X. Fang, J. Gong, and N. Zheng, “Pd Nanosheet-Covered Hollow Mesoporous Silica Nanoparticles as a Platform for the Chemo-Photothermal Treatment of Cancer Cells,” Small8 (2012): 3816-3822. d) J. R. Melamed, R. S. Edelstein, and E. S. Day, “Elucidating the Fundamental Mechanisms of Cell Death Triggered by Photothermal Therapy,” ACS Nano9 (2015): 6-11.

[87] a) X. Zhu, W. Feng, J. Chang, et al., “Temperature-feedback Upconversion Nanocomposite for Accurate Photothermal Therapy at Facile Temperature,” Nature Communications7 (2016): 10437. b) G. Gao, Y. W. Jiang, W. Sun, et al., “Molecular Targeting-Mediated Mild-Temperature Photothermal Therapy With a Smart Albumin-Based Nanodrug,” Small15 (2019): e1900501.

[88] a) M. Nivon, E. Richet, P. Codogno, A. P. Arrigo, and C. Kretz-Remy, “Autophagy Activation by NFκB is Essential for Cell Survival After Heat Shock,” Autophagy5 (2009): 766-783. b) Y. Zhang and S. K. Calderwood, “Autophagy, Protein Aggregation and Hyperthermia: A Mini-Review,” International Journal of Hyperthermia27 (2011): 409-414.

[89] a) X. Ren, Y. Chen, H. Peng, et al., “Blocking Autophagic Flux Enhances Iron Oxide Nanoparticle Photothermal Therapeutic Efficiency in Cancer Treatment,” ACS Applied Materials & Interfaces10 (2018): 27701-27711. b) T. Chen, D. Cen, Z. Ren, et al., “Bismuth Embedded Silica Nanoparticles Loaded With Autophagy Suppressant to Promote Photothermal Therapy,” Biomaterials221 (2019): 119419. c) X. Wu, Y. Wu, Z. Wang, et al., “A Cascade-Targeting Nanocapsule for Enhanced Photothermal Tumor Therapy With Aid of Autophagy Inhibition,” Advanced Healthcare Materials7 (2018): e1800121. d) X. Wang, Y. Li, Y. Cui, et al., “Hierarchical Assembly of Dual-responsive Biomineralized Polydopamine-Calcium Phosphate Nanocomposites for Enhancing Chemo-photothermal Therapy by Autophagy Inhibition,” Biomater Sci8 (2020): 5172-5182. e) Y. Zhang, R. Sha, L. Zhang, et al., “Harnessing Copper-Palladium Alloy Tetrapod Nanoparticle-Induced Pro-Survival Autophagy for Optimized Photothermal Therapy of Drug-Resistant Cancer,” Nature Communications9 (2018): 4236.

[90] F. Ding, X. Gao, X. Huang, et al., “Polydopamine-Coated Nucleic Acid Nanogel for siRNA-Mediated Low-Temperature Photothermal Therapy,” Biomaterials245 (2020): 119976.

[91] Y. Ma, H. Chen, B. Hao, et al., “A Chloroquine-Loaded Prussian Blue Platform With Controllable Autophagy Inhibition for Enhanced Photothermal Therapy,” Journal of Materials Chemistry B6 (2018): 5854-5859.

[92] a) T. Zhang, B. Wu, O. U. Akakuru, et al., “Hsp90 Inhibitor-Loaded IR780 Micelles for Mitochondria-Targeted Mild-Temperature Photothermal Therapy in Xenograft Models of Human Breast Cancer,” Cancer Letters500 (2021): 41-50. b) W. H. Chen, G. F. Luo, Q. Lei, et al., “Overcoming the Heat Endurance of Tumor Cells by Interfering With the Anaerobic Glycolysis Metabolism for Improved Photothermal Therapy,” ACS Nano11 (2017): 1419-1431. c) Z. Zhou, Y. Yan, K. Hu, et al., “Autophagy Inhibition Enabled Efficient Photothermal Therapy at a Mild Temperature,” Biomaterials141 (2017): 116-124.

[93] L. Shao, Y. Li, F. Huang, et al., “Complementary Autophagy Inhibition and Glucose Metabolism With Rattle-structured Polydopamine@Mesoporous Silica Nanoparticles for Augmented Low-temperature Photothermal Therapy and In Vivo Photoacoustic Imaging,” Theranostics10 (2020): 7273-7286.

[94] H. Xiao, X. Li, B. Li, et al., “Nanodrug Inducing Autophagy Inhibition and Mitochondria Dysfunction for Potentiating Tumor Photo-Immunotherapy,” Small19 (2023): e2300280.

[95] a) T. Di Ianni, R. J. C. Bose, U. K. Sukumar, et al., “Ultrasound/Microbubble-Mediated Targeted Delivery of Anticancer MicroRNA-Loaded Nanoparticles to Deep Tissues in Pigs,” J Control Release309 (2019): 1-10. b) L. Tu, Z. Liao, Z. Luo, Y.-L. Wu, A. Herrmann, and S. Huo, “Ultrasound-Controlled Drug Release and Drug Activation for Cancer Therapy,” Exploration2021, 1, 20210023.

[96] G. Canavese, A. Ancona, L. Racca, et al., “Nanoparticle-Assisted Ultrasound: A Special Focus on Sonodynamic Therapy Against Cancer,” Chemical Engineering Journal340 (2018): 155-172.

[97] a) P. P. Laissue, R. A. Alghamdi, P. Tomancak, E. G. Reynaud, and H. Shroff, “Assessing Phototoxicity in Live Fluorescence Imaging,” Nature Methods14 (2017): 657-661. b) X. Guan, H. H. Yin, X. H. Xu, et al., “Tumor Metabolism-Engineered Composite Nanoplatforms Potentiate Sonodynamic Therapy via Reshaping Tumor Microenvironment and Facilitating Electron-Hole Pairs″ Separation” Advanced Functional Materials30, no. 27 (2020): 2000326. c) Z. Luo, Z. Li, Z. Xie, et al., “Rethinking Nano-TiO₂ Safety: Overview of Toxic Effects in Humans and Aquatic Animals,” Small16 (2020): e2002019.

[98] F. Qu, P. Wang, K. Zhang, et al., “Manipulation of Mitophagy by “All-in-One” Nanosensitizer Augments Sonodynamic Glioma Therapy,” Autophagy16 (2020): 1413-1435.

[99] Q. Feng, X. Yang, Y. Hao, et al., “Cancer Cell Membrane-Biomimetic Nanoplatform for Enhanced Sonodynamic Therapy on Breast Cancer via Autophagy Regulation Strategy,” ACS Applied Materials & Interfaces11 (2019): 32729-32738.

[100] L. Zhou, M. Huo, X. Qian, et al., “Autophagy Blockade Synergistically Enhances Nanosonosensitizer-enabled Sonodynamic Cancer Nanotherapeutics,” Journal of Nanobiotechnology19 (2021): 112.

[101] S. Ma, H. Miao, Y. Luo, et al., “FePt/GO Nanosheets Suppress Proliferation, Enhance Radiosensitization and Induce Autophagy of Human Non-Small Cell Lung Cancer Cells,” Int J Biol Sci15 (2019): 999-1009.

[102] Z. Liu, L. Xiong, G. Ouyang, et al., “Investigation of Copper Cysteamine Nanoparticles as a New Type of Radiosensitiers for Colorectal Carcinoma Treatment,” Scientific Reports7 (2017): 9290.

[103] P. Mroz, A. Yaroslavsky, G. B. Kharkwal, and M. R. Hamblin, “Cell Death Pathways in Photodynamic Therapy of Cancer,” Cancers (Basel)3 (2011): 2516-2539.

[104] Z. Zhou, Y. Yan, L. Wang, Q. Zhang, and Y. Cheng, “Melanin-Like Nanoparticles Decorated With an Autophagy-Inducing Peptide for Efficient Targeted Photothermal Therapy,” Biomaterials203 (2019): 63-72.

[105] T. Appidi, D. B. Pemmaraju, R. A. Khan, et al., “Light-Triggered Selective ROS-Dependent Autophagy by Bioactive Nanoliposomes for Efficient Cancer Theranostics,” Nanoscale12 (2020): 2028-2039.

[106] M. Zhang, H. S. Kim, T. Jin, and W. K. Moon, “Near-Infrared Photothermal Therapy Using EGFR-Targeted Gold Nanoparticles Increases Autophagic Cell Death in Breast Cancer,” Journal of Photochemistry and Photobiology B: Biology170 (2017): 58-64.

[107] X. Zhao, T. Qi, C. Kong, et al., “Photothermal Exposure of Polydopamine-Coated Branched Au-Ag Nanoparticles Induces Cell Cycle Arrest, Apoptosis, and Autophagy in Human Bladder Cancer Cells,” Int J Nanomedicine13 (2018): 6413-6428.

[108] Y. Wang and Y. Xia, “Near-infrared Optically Active Cu_2−XS Nanocrystals: Sacrificial Template-Ligand Exchange Integration Fabrication and Chirality Dependent Autophagy Effects,” Journal of Materials Chemistry B8 (2020): 7921-7930.

[109] a) M. H. E. Jansen, J. Kessels, P. J. Nelemans, et al., “Randomized Trial of Four Treatment Approaches for Actinic Keratosis,” New England Journal of Medicine380 (2019): 935-946. b) Y. Zhang, H. Zhang, L. Zhang, et al., “Modified 5-Aminolevulinic Acid Photodynamic Therapy to Reduce Pain in the Treatment of Moderate to Severe Acne Vulgaris: A Prospective, Randomized, Split-Face Study,” Journal of the American Academy of Dermatology84 (2021): 218-220.

[110] R. Baskaran, J. Lee, and S. G. Yang, “Clinical Development of Photodynamic Agents and Therapeutic Applications,” Biomaterials Research22 (2018): 25.

[111] J. P. Celli, B. Q. Spring, I. Rizvi, et al., “Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization,” Chemical Reviews110 (2010): 2795-2838.

[112] J. J. Reiners., P. Agostinis, K. Berg, N. L. Oleinick, and D. Kessel, “Assessing Autophagy in the Context of Photodynamic Therapy,” Autophagy6 (2010): 7-18.

[113] T. Wang, J. Hu, H. Luo, et al., “Photosensitizer and Autophagy Promoter Coloaded ROS-Responsive Dendrimer-Assembled Carrier for Synergistic Enhancement of Tumor Growth Suppression,” Small14 (2018): e1802337.

[114] Z. Mohammadalipour, M. Rahmati, A. Khataee, and M. A. Moosavi, “Differential Effects of N-TiO₂ Nanoparticle and Its Photo-Activated Form on Autophagy and Necroptosis in Human Melanoma A375 Cells,” Journal of Cellular Physiology235 (2020): 8246-8259.

[115] T. C. Pham, V. N. Nguyen, Y. Choi, S. Lee, and J. Yoon, “Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy,” Chemical Reviews121 (2021): 13454-13619.

[116] B. Ghaemi, A. Moshiri, I. K. Herrmann, et al., “Supramolecular Insights Into Domino Effects of Ag@ZnO-Induced Oxidative Stress in Melanoma Cancer Cells,” ACS Applied Materials & Interfaces11 (2019): 46408-46418.

[117] X. Wang, M. Li, K. Ren, et al., “On-Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin-Induced Cancer Immunotherapy,” Advanced Materials32 (2020): e2002160.

[118] X. Long, H. Wang, J. Yan, et al., “Tailor-Made Autophagy Cascade Amplification Polymeric Nanoparticles for Enhanced Tumor Immunotherapy,” Small19 (2023): e2207898.

[119] a) F. Z. Wang, L. Xing, Z. H. Tang, et al., “Codelivery of Doxorubicin and shAkt1 by Poly(Ethylenimine)-Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy,” Molecular Pharmacology13 (2016): 1298-1307. b) J. M. de Lima, L. R. C. Castellano, P. R. F. Bonan, et al., “Chitosan/PCL Nanoparticles Can Improve Anti-Neoplastic Activity of 5-Fluorouracil in Head and Neck Cancer Through Autophagy Activation,” International Journal of Biochemistry & Cell Biology134 (2021): 105964. c) Y. Y. Wang, D. D. Zhang, Y. Y. Kong, et al., “CS/PAA@TPGS/PLGA Nanoparticles With Intracellular pH-Sensitive Sequential Release for Delivering Drug to the Nucleus of MDR Cells,” Colloids and Surfaces. B, Biointerfaces145 (2016): 716-727. d) X. Wang, L. Yang, H. Zhang, et al., “Fluorescent Magnetic PEI-PLGA Nanoparticles Loaded With Paclitaxel for Concurrent Cell Imaging, Enhanced Apoptosis and Autophagy in Human Brain Cancer,” Colloids and Surfaces. B, Biointerfaces172 (2018): 708-717. e) L. Ding, Q. Wang, M. Shen, et al., “Thermoresponsive Nanocomposite Gel for Local Drug Delivery to Suppress the Growth of Glioma by Inducing Autophagy,” Autophagy13 (2017): 1176-1190.

[120] a) Y. Hu, H. R. Zhang, L. Dong, et al., “Enhancing Tumor Chemotherapy and Overcoming Drug Resistance Through Autophagy-Mediated Intracellular Dissolution of Zinc Oxide Nanoparticles,” Nanoscale11 (2019): 11789-11807. b) G. Wang, K. Qian, and X. Mei, “A Theranostic Nanoplatform: Magneto-Gold@Fluorescence Polymer Nanoparticles for Tumor Targeting T₁ & T₂-MRI/CT/NIR Fluorescence Imaging and Induction of Genuine Autophagy Mediated Chemotherapy,” Nanoscale10 (2018): 10467-10478.

[121] R. Hu, C. Dai, X. Dai, et al., “Topology Regulation of Nanomedicine for Autophagy-augmented Ferroptosis and Cancer Immunotherapy,” Science Bulletin (Beijing)68 (2023): 77-94.

[122] M. Li, D. Zhao, J. Yan, et al., “A Redox-Triggered Autophagy-Induced Nanoplatform With PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy,” ACS Nano18 (2024): 12870-12884.

[123] X. Li, Y. Wang, Y. Chen, et al., “Hierarchically Constructed Selenium-Doped Bone-Mimetic Nanoparticles Promote ROS-Mediated Autophagy and Apoptosis for Bone Tumor Inhibition,” Biomaterials257 (2020): 120253.

[124] Q. Guo, Q. Chen, Y. Zhang, et al., “Click-Nucleic-Acid-Containing Codelivery System Inducing Collapse of Cellular Homeostasis for Tumor Therapy Through Bidirectional Regulation of Autophagy and Glycolysis,” ACS Applied Materials & Interfaces12 (2020): 57757-57767.

[125] C. L. Luo, Y. Q. Liu, P. Wang, et al., “The Effect of Quercetin Nanoparticle on Cervical Cancer Progression by Inducing Apoptosis, Autophagy and Anti-Proliferation via JAK2 Suppression,” Biomedicine & Pharmacotherapy82 (2016): 595-605.

[126] M. Lou, L. N. Zhang, P. G. Ji, et al., “Quercetin Nanoparticles Induced Autophagy and Apoptosis Through AKT/ERK/Caspase-3 Signaling Pathway in Human Neuroglioma Cells: In Vitro and In Vivo,” Biomedicine & Pharmacotherapy84 (2016): 1-9.

[127] Y. Wang, Y. X. Lin, J. Wang, et al., “In Situ Manipulation of Dendritic Cells by an Autophagy-Regulative Nanoactivator Enables Effective Cancer Immunotherapy,” ACS Nano13 (2019): 7568-7577.

RIGHTS & PERMISSIONS

2025 The Author(s). Exploration published by Henan University and John Wiley & Sons Australia, Ltd.